Nevirapin Viatris 400 mg, Retardtabletten

7680667650027 CH-66765 Tabletten

Associated product:

NEVIRAPIN Viatris cpr ret 400 mg 30 pce
Nevirapin Viatris 400 mg, Retardtabletten
Nevirapin Viatris 400 mg, Retardtabletten
Nevirapin Viatris 400 mg, Retardtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/03/2025
Patient information leaflet
Français
17/03/2025
Patient information leaflet
Italien
17/03/2025
Summary of Product Characteristics
Allemand
17/03/2025
Summary of Product Characteristics
Français
17/03/2025
Summary of Product Characteristics
Italien
17/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
398.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
710.0 UG Substance HBESI

Reimbursement information

Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2018

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
66765
Drug name
Nevirapin Viatris, Retardtabletten
Galenic form
RETT
ATC Code
J05AG01
Authorization status
Z
Dispensing category
A
First authorization
12/09/2018
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
NEVIRAPIN Viatris cpr ret 400 mg 30 pce
Description (DE)
NEVIRAPIN Viatris Ret Tabl 400 mg 30 Stk
Market launch
12/09/2018
Narcotic (BTM)
No

Original drug

Viramune, Retardtabletten
GTIN: 7680620770014
CHF 211.90
View original

Other package sizes (1)

NEVIRAPIN Mylan cpr ret 400 mg 30 pce
None None
GTIN: 7680667650010
Not in V1